Xcout IntelSign inSubscribe

ElevateBio competitors & alternatives

BiotechUnited States

The 12 closest competitors and alternatives to ElevateBio among biotech companies — ranked by similarity to what ElevateBio actually does, not by market-cap band.

12Competitors listed

Subscribe to see ElevateBio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About ElevateBio

ElevateBio is a biotechnology company that builds and operates cell and gene therapy companies and provides development, manufacturing, and technology capabilities through its platform, including BaseCamp. It serves biotech and pharmaceutical organizations developing advanced therapies, as well as supporting the creation of new therapeutic companies.

ElevateBio at a glance

ElevateBio is a biotech company headquartered in United States. Xcout recorded 41 job postings from ElevateBio in the last 90 days, naming tools such as SAP.

Hiring at ElevateBio

Xcout recorded 41 job postings from ElevateBio in the last 90 days, from a hiring record Xcout has kept since August 2026.

Tools named in ElevateBio's job postings

SAP

The weekly hiring trend, the roles and locations behind it — see ElevateBio's hiring signals →

Top 12 ElevateBio competitors

Ranked by semantic similarity — how close each company is to ElevateBio by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

OXFORD BIOMEDICA PLCOXB · BiotechOxford, United Kingdom
64% matchPublic

Similar biotech company

Oxford Biomedica plc is a biopharmaceutical firm focused on the discovery, advancement, and sophisticated bioprocessing of innovative cell and gene therapies. Operating globally, with a strong presence across Europe, the company organizes its activities into two segments: Platform and Product. Its proprietary LentiVector platform technology facilitates the integration of genes into non-dividing cells, such as neurological cells in the brain and retinal cells in the eye, and can incorporate diverse therapeutic genes. The company's developmental pipeline includes promising candidates like Axo-Lenti-PD, a gene-based treatment for Parkinson's disease. Other pre-clinical stage programs feature OXB-302, targeting haematological tumors, and OXB-401, OXB-40X, and OXB-40Y, all addressing liver indications. Oxford Biomedica maintains numerous strategic alliances with prominent pharmaceutical entities such as Novartis, Bristol Myers Squibb, Sio Gene Therapies, Orchard Therapeutics, Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Immatics, Arcellx, and the Vaccines Manufacturing and Innovation Centre. Additionally, it engages in research collaborations, including a partnership with Circularis Biotechnologies to identify novel tissue-specific promoters for in vivo lentiviral gene therapy, Virica Biotech for scaling viral medicines, Isolere Bio for enhancing downstream manufacturing efficiencies of biologics, and BiologIC Technologies for utilizing a novel biocomputer system in viral vector development. Founded in 1995, Oxford Biomedica plc is headquartered in Oxford, United Kingdom.

Market cap$808M
Employees986
OXFORD BIOMEDICA PLC competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of ElevateBio and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for ElevateBioand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →